US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 14.945
  • +0.065+0.44%
Trading Apr 30 10:31 ET
814.85MMarket Cap-11.97P/E (TTM)

Bicara Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
112.51%489.71M
112.51%489.71M
--520.76M
--203.86M
5,442.09%230.44M
--230.44M
--4.16M
-Cash and cash equivalents
112.51%489.71M
112.51%489.71M
--520.76M
--203.86M
5,442.09%230.44M
--230.44M
--4.16M
Other current assets
1,925.59%12.82M
1,925.59%12.82M
--756K
--2.22M
-23.37%633K
--633K
--826K
Total current assets
117.48%502.53M
117.48%502.53M
--521.51M
--206.08M
4,536.30%231.07M
--231.07M
--4.98M
Non current assets
Net PPE
3.68%845K
3.68%845K
--544K
--619K
28.14%815K
--815K
--636K
-Gross PPE
3.68%845K
3.68%845K
--544K
--619K
28.14%815K
--815K
--636K
Other non current assets
216.05%6.62M
216.05%6.62M
--2.12M
--2.09M
93.35%2.09M
--2.09M
--1.08M
Total non current assets
156.55%7.46M
156.55%7.46M
--2.66M
--2.71M
69.23%2.91M
--2.91M
--1.72M
Total assets
117.96%510M
117.96%510M
--524.17M
--208.78M
3,390.71%233.98M
--233.98M
--6.7M
Liabilities
Current liabilities
Payables
41.49%4.51M
41.49%4.51M
--1.96M
--4.68M
-37.98%3.19M
--3.19M
--5.14M
-accounts payable
41.49%4.51M
41.49%4.51M
--1.96M
--4.68M
-37.98%3.19M
--3.19M
--5.14M
Current accrued expenses
-0.81%9.79M
-0.81%9.79M
--10.4M
--9.97M
-43.85%9.87M
--9.87M
--17.58M
Current debt and capital lease obligation
112.98%607K
112.98%607K
--308K
--300K
--285K
--285K
----
-Current capital lease obligation
112.98%607K
112.98%607K
--308K
--300K
--285K
--285K
--0
Current liabilities
19.26%17.99M
19.26%17.99M
--14.48M
--16.07M
-36.87%15.09M
--15.09M
--23.9M
Non current liabilities
Long term debt and capital lease obligation
-64.78%131K
-64.78%131K
--137K
--217K
--372K
--372K
--0
-Long term capital lease obligation
-64.78%131K
-64.78%131K
--137K
--217K
--372K
--372K
--0
Preferred securities outside stock equity
--0
--0
--0
--367.28M
350.51%367.28M
--367.28M
--81.53M
Other non current liabilities
----
----
----
----
-80.00%17K
--17K
--85K
Total non current liabilities
-99.96%131K
-99.96%131K
--137K
--367.49M
350.52%367.67M
--367.67M
--81.61M
Total liabilities
-95.27%18.12M
-95.27%18.12M
--14.62M
--383.56M
262.78%382.75M
--382.75M
--105.51M
Shareholders'equity
Share capital
250.00%7K
250.00%7K
--7K
--2K
0.00%2K
--2K
--2K
-common stock
250.00%7K
250.00%7K
--7K
--2K
0.00%2K
--2K
--2K
-Preferred stock
--0
--0
--0
----
--0
--0
----
Retained earnings
-44.44%-221.02M
-44.44%-221.02M
---200.06M
---182.58M
-51.45%-153.02M
---153.02M
---101.04M
Paid-in capital
16,673.74%712.88M
16,673.74%712.88M
--709.61M
--7.8M
90.50%4.25M
--4.25M
--2.23M
Total stockholders'equity
430.63%491.88M
430.63%491.88M
--509.56M
---174.78M
-50.57%-148.77M
---148.77M
---98.8M
Total equity
430.63%491.88M
430.63%491.88M
--509.56M
---174.78M
-50.57%-148.77M
---148.77M
---98.8M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 112.51%489.71M112.51%489.71M--520.76M--203.86M5,442.09%230.44M--230.44M--4.16M
-Cash and cash equivalents 112.51%489.71M112.51%489.71M--520.76M--203.86M5,442.09%230.44M--230.44M--4.16M
Other current assets 1,925.59%12.82M1,925.59%12.82M--756K--2.22M-23.37%633K--633K--826K
Total current assets 117.48%502.53M117.48%502.53M--521.51M--206.08M4,536.30%231.07M--231.07M--4.98M
Non current assets
Net PPE 3.68%845K3.68%845K--544K--619K28.14%815K--815K--636K
-Gross PPE 3.68%845K3.68%845K--544K--619K28.14%815K--815K--636K
Other non current assets 216.05%6.62M216.05%6.62M--2.12M--2.09M93.35%2.09M--2.09M--1.08M
Total non current assets 156.55%7.46M156.55%7.46M--2.66M--2.71M69.23%2.91M--2.91M--1.72M
Total assets 117.96%510M117.96%510M--524.17M--208.78M3,390.71%233.98M--233.98M--6.7M
Liabilities
Current liabilities
Payables 41.49%4.51M41.49%4.51M--1.96M--4.68M-37.98%3.19M--3.19M--5.14M
-accounts payable 41.49%4.51M41.49%4.51M--1.96M--4.68M-37.98%3.19M--3.19M--5.14M
Current accrued expenses -0.81%9.79M-0.81%9.79M--10.4M--9.97M-43.85%9.87M--9.87M--17.58M
Current debt and capital lease obligation 112.98%607K112.98%607K--308K--300K--285K--285K----
-Current capital lease obligation 112.98%607K112.98%607K--308K--300K--285K--285K--0
Current liabilities 19.26%17.99M19.26%17.99M--14.48M--16.07M-36.87%15.09M--15.09M--23.9M
Non current liabilities
Long term debt and capital lease obligation -64.78%131K-64.78%131K--137K--217K--372K--372K--0
-Long term capital lease obligation -64.78%131K-64.78%131K--137K--217K--372K--372K--0
Preferred securities outside stock equity --0--0--0--367.28M350.51%367.28M--367.28M--81.53M
Other non current liabilities -----------------80.00%17K--17K--85K
Total non current liabilities -99.96%131K-99.96%131K--137K--367.49M350.52%367.67M--367.67M--81.61M
Total liabilities -95.27%18.12M-95.27%18.12M--14.62M--383.56M262.78%382.75M--382.75M--105.51M
Shareholders'equity
Share capital 250.00%7K250.00%7K--7K--2K0.00%2K--2K--2K
-common stock 250.00%7K250.00%7K--7K--2K0.00%2K--2K--2K
-Preferred stock --0--0--0------0--0----
Retained earnings -44.44%-221.02M-44.44%-221.02M---200.06M---182.58M-51.45%-153.02M---153.02M---101.04M
Paid-in capital 16,673.74%712.88M16,673.74%712.88M--709.61M--7.8M90.50%4.25M--4.25M--2.23M
Total stockholders'equity 430.63%491.88M430.63%491.88M--509.56M---174.78M-50.57%-148.77M---148.77M---98.8M
Total equity 430.63%491.88M430.63%491.88M--509.56M---174.78M-50.57%-148.77M---148.77M---98.8M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More